期刊文献+

酮洛芬贴片体外透皮释放方法学研究 被引量:1

Study on transdermal release in vitro of ketoprofen patches
暂未订购
导出
摘要 目的:建立酮洛芬贴片体外透皮释放方法学。方法:采用HPLC法测定释放液中酮洛芬的含量,测定条件:Diamonsilc18色谱柱(150mm×4.6mm,5μm),流动相为pH3.5磷酸盐缓冲液.乙腈.水(2:53:45),检测波长为253nm,流速为1.0mL·min-1,柱温25℃。以裸鼠皮肤为实验皮肤,采用Frans扩散池方法进行三批酮洛芬贴片样品的体外透皮实验。结果:在该HPLC条件下,酮洛芬与其他杂质分离良好,进样量在0.509~40.72μg·mL-1时,酮洛芬浓度与峰面积呈良好的线性关系(r=0.9999),回收率为101.09%,RSD为1.23%。三批酮洛芬贴片样品的透皮释放速率分别为18.157,17.973,20.001gg·cm-2.h-1,药物透皮释放符合零级动力学过程。结论:本文建立的酮洛芬贴片体外透皮释放方法简便,重现性好,可以用于控制产品质量。 Objective: To establish a test method for transdermal release of ketoprofen patch. Methods: An HPLC method was used to determine the content of ketoprofen. A Diamonsil C18 cohmm (150 mm ×4.6 mm, 5μm) was used for separation, the mobile phase consisted of phosphate buffer solution (pH3.5)-acetonitrile-water (2 : 53 : 45) at the flow rate of 1.0 mL. min-~, and the detection wavelength was set at 253 nm, column temperature was 25 ~C. The in vitro transdermal test was performed using nude mice skin and Frans diffusive pool, and three batch samples were verified by this method. Results: Ketoprofen was separated well from other impurity in this chromatogram condition. The calibration curve was linear in the range of 0.509 - 40.72 μg-mL-1 (r = 0.999 9). The average recovery was 101.09% and the RSD was 1.23%. The transdermal release rates of ketoprofen in three batches of patches were 18.157, 17.973 and 20.001μg·cm2.h-1, respectively. The release of ketoprofen patch followed zero order kinetic model. Conclusion: The method was simple and reproducible, which can be used to control product quality.
出处 《中国药物应用与监测》 CAS 2012年第6期324-327,共4页 Chinese Journal of Drug Application and Monitoring
关键词 酮洛芬 贴片 体外 透皮释放速率 Ketoprofen Patch In vitro Transdermal release rate
  • 相关文献

参考文献10

  • 1Hussain A, Khan GM, Shah SU, et al. Development of a novel ketoprofen transdermal patch: effect of almond oil as penetration enhancers on in-vitro and ex-vivo penetration of ketoprofen through rabbit skin[J]. Pak J Pharm Sci, 2012, 25(1): 227-232.
  • 2Atarashi K, Takano M, Kato S, et al. Addition of UVA- absorber butyl methoxy dibenzoylmethane to topical ketoprofen formulation reduces ketoprofen-photoallergic reacti0n[J]. J Photochem Photobiol B, 2012, 113: 56-62.
  • 3卜海涛,何文,王军,陈志明.酮洛芬醇质体凝胶与脂质体凝胶的体外经皮渗透动力学的比较研究[J].广东药学院学报,2012,28(4):366-369. 被引量:11
  • 4Coaccioli S. Ketoprofen 2.5% gel: a clinical overview[J]. Eur Rev Med Pharmacol Sci, 2011, 15(8): 943-949.
  • 5屠锡得,张均寿,朱家壁,药剂学[M].第3版,北京:人民卫生出版社,2002:474.
  • 6郑俊民.经皮给药新剂型[M].第1版.北京:人民卫生出版社,2007.
  • 7胡英,吴遥遥,吴争,梁文权,高建青.α-细辛醚的黏胶分散型经皮贴剂研究[J].中国新药杂志,2009,18(10):949-952. 被引量:3
  • 8Kawai S, Uchida E, Kondo M, et al. Efficacy and safety of ketoprofen patch in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled study[J]. J Clin Pharmacol, 2010, 50( 10): 1171-1179.
  • 9Adachi H, Ioppolo F, Paoloni M, et al. Physical characteristics, pharmacological properties and clinical efficacy of the ketoprofen patch: a new patch formulation[J]. Eur Rev Med Pharmacol Sci, 2011, 15(7): 823-830.
  • 10王英姿,杜守颖,惠建国.高乌甲素凝胶透皮吸收实验皮肤的选择研究[J].中医学报,2011,26(11):1344-1345. 被引量:3

二级参考文献19

  • 1赵江琼,易以木,吴斌.酮洛芬凝胶的制备及质量控制[J].中国药房,2007,18(13):1007-1009. 被引量:6
  • 2陈志明,宋金春.酮洛芬脂质体凝胶的研制及体外经皮渗透动力学考察[J].中国药师,2009,12(2):159-162. 被引量:9
  • 3吴争,高建青,陈海靓,胡英,梁文权.α-细辛醚储库型贴片研究[J].中国中药杂志,2007,32(6):484-487. 被引量:4
  • 4吴闯.α-细辛脑的研究进展[J].中国药学杂志,1997,32(3):129-132. 被引量:153
  • 5唐希灿 朱梅英 等.刺乌头碱氢溴酸盐的药理作用研究[J].药学学报,1983,18(8):579-584.
  • 6AQIL M,ALI A. Monolithic matrix type transdermal drug delivery systems of pinacidil munohydrate:in vitro characterisation[ J]. Euro J Pharm Biopharm,2002,S4( 2 ) :161 - 164.
  • 7KOTIYAN PN, VAVIA PR. Eudragits: roles as crystallization inhibitors in drug-in-adhesive transdermal systems of estradiol [ J ]. Eur J Pharm Biopharm,2001,52 ( 2 ) : 173 - 180.
  • 8刘宇 王东凯.α-细辛脑-β-环糊精包合物的制备及体外溶出度测定.中国药剂学杂志,2003,1(4):150-150.
  • 9KIM J H, CHOI H K. Effect of additives on the crystallization and the permeation of ketoprofen from adhesive matrix[ J]. lnt J Pharm ,2002,236:81 - 85.
  • 10SHEU M T, CHEN Ling-chun, HO H O. Simultaneous optimization of percutaneous delivery and adhesion for ketoorofen poultice [ ] 1. Int J Pharm.2002.233:257 - 262.

共引文献16

同被引文献12

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部